Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Walter Hunkeler is active.

Publication


Featured researches published by Walter Hunkeler.


Pharmacology, Biochemistry and Behavior | 1988

Ro 15-4513: Partial inverse agonism at the BZR and interaction with ethanol☆

E.Pietro Bonetti; W. P. Burkard; Markus Gabl; Walter Hunkeler; H.P. Lorez; James R. Martin; Hanns Moehler; Wolfgang Osterrieder; Lorenzo Pieri; Petar Polc; J. Grayson Richards; R. Schaffner; Richard Scherschlicht; Peter Schoch; W. Haefely

The imidazobenzodiazepinone derivative Ro 15-4513 has the activity profile of a partial inverse (low efficacy) agonist at the benzodiazepine receptor (BZR). It reverses central nervous depressant effects of diazepam, and, in part, of phenobarbitone and ethanol in mice, rats and cats in behavioural, electrophysiological, and neurochemical paradigms. The interaction of Ro 15-4513 with barbiturates and ethanol is due to its inverse agonistic (negative allosteric modulatory) property at the BZR, as it was reversed by the selective BZR blocker flumazenil (Ro 15-1788). In the present experiment situations, other BZR partial inverse agonists in subconvulsant or overt convulsant doses were less effective against ethanol effects than Ro 15-4513. Possible mechanisms for this differential activity of BZR inverse agonists are discussed.


The Journal of Nuclear Medicine | 1990

In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.

Hans-Frieder Beer; Peter Bläuenstein; Peter Hasler; B. Delaloye; Georg Riccabona; Isolde Bangerl; Walter Hunkeler; Erico P. Bonetti; Lorenzo Pieri; J. Grayson Richards; P. August Schubiger


Archive | 2000

4-phenyl-pyridine derivatives

Michael Bös; Quirico Branca; Guido Galley; Thierry Godel; Torsten Hoffmann; Walter Hunkeler; Patrick Schnider; Heinz Stadler


Archive | 2000

4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists

Michael Boes; Quirico Branca; Guido Galley; Thierry Godel; Torsten Hoffmann; Walter Hunkeler; Patrick Schnider; Heinz Stadler


Archive | 2000

Amino-triazolopyridine derivatives

Gerda Huber Trottmann; Walter Hunkeler; Roland Jakob-Roetne; Gavin J. Kilpatrick; Matthias Nettekoven; Claus Riemer


Bioorganic & Medicinal Chemistry Letters | 2006

Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists

Torsten Hoffmann; Michael Bös; Heinz Stadler; Patrick Schnider; Walter Hunkeler; Thierry Godel; Guido Galley; Theresa M. Ballard; Guy A. Higgins; Sonia Maria Poli; Andrew Sleight


Archive | 1980

Imidazodiazepine derivatives, process and intermediates for their preparation, medicaments containing them and their therapeutic application

W. Haefely; Walter Hunkeler; Emilio Kyburz; Hanns Möhler; Lorenzo Pieri; Petar Polc; Max Gerecke


Archive | 2000

Phenyl- and pyridinyl derivatives

Guido Galley; Thierry Godel; Torsten Hoffmann; Walter Hunkeler; Patrick Schnider; Heinz Stadler; Michael Boes


Archive | 1980

Urea derivatives, process and intermediates for their preparation, medicaments containing such a urea derivative and its therapeutical use

Walter Hunkeler; Emilio Kyburz


Archive | 1982

Imidazodiazepines, intermediate products and process for their preparation, and medicines containing them

Walter Hunkeler; Emilio Kyburz

Collaboration


Dive into the Walter Hunkeler's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge